Stifel Nicolaus Reaffirms Their Buy Rating on PepGen Inc. (PEPG)
Analysts Are Bullish on Top Healthcare Stocks: Generation Bio (GBIO), PepGen Inc. (PEPG)
PepGen Analyst Ratings
Wedbush Maintains Outperform on PepGen, Lowers Price Target to $20
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), ITeos Therapeutics (ITOS) and Rezolute (RZLT)
Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (PEPG), BridgeBio Pharma (BBIO) and Amedisys (AMED)
Buy Rating Affirmed for PepGen Inc. on Strong Prospects in DMD Treatment and Promising EDO Platform
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), Crispr Therapeutics AG (CRSP) and BridgeBio Pharma (BBIO)
PepGen Analyst Ratings
Wedbush Keeps Their Buy Rating on PepGen Inc. (PEPG)
Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (PEPG), Viridian Therapeutics (VRDN) and Blueprint Medicines (BPMC)
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), 4D Molecular Therapeutics (FDMT) and Compass Therapeutics (CMPX)
Analysts' Top Healthcare Picks: Immuneering (IMRX), PepGen Inc. (PEPG)
Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), GoodRx Holdings (GDRX)
HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $26 Price Target
PepGen Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), Cidara Therapeutics (CDTX)
HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $26 Price Target
PepGen Analyst Ratings
The Latest Analyst Ratings for PepGen
No Data